Evidence map›Paper›PMID 30642609›Full record

ArticleEuropean urology2019

Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making.

Alicia K Morgans, Charles J Ryan

Abstract readEditorialComment
In one paragraph

Article in European urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Alicia K MorgansDivision of Hematology/Oncology, Department of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: alicia.morgans@northwestern.edu.
Charles J RyanDepartment of Medicine and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.

Funding

Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancerP50CA180995 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., HUSSAIN, MAHA H · 2015 to 2025
$19.9M
NCI NIH HHS P50 CA180995
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic Neoplasms, Castration-ResistantQuality of LifeAndrostenesBenzamidesDecision MakingHumansMaleNitrilesPhenylthiohydantoinPrednisoneabirateroneAndrostenesBenzamidesenzalutamideNitrilesPhenylthiohydantoinPrednisone

Identifiers

PMID30642609
PMCPMC6659108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.